An impulsive X4.2 solar flare sparked strong radio blackouts across Africa and Europe as the giant sunspot continues to rage. When you purchase through links on our site, we may earn an affiliate ...

I can’t think of another e-reader from a company nobody has ever heard of receiving this much attention from users who buy it and from tech media covering it. Of course, I am talking about the Xteink ...

With buttons instead of a touchscreen, the Xteink X4 can be a challenge to use, but a growing community is fixing that. With buttons instead of a touchscreen, the Xteink X4 can be a challenge to use, ...

Personal electric aircraft have teased us for years. They look futuristic, promise freedom from traffic, and usually come with prices that put them out of reach or timelines that feel uncertain.

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. Performance is good and exactly what you'd expect for ...

The X4 utilizes a semi-solid-state dual battery pack, which reportedly allows it to execute a safe landing even if one battery module fails. It also packs an emergency parachute system, should things ...

Joel Cunningham is Lifehacker’s Deputy Editor. He has 15 years of experience as a writer and editor. Previously, he was managing editor of content marketing for Barnes & Noble, where he founded the ...

We adhere to a strict editorial policy, ensuring that our content is crafted by an in-house team of experts in technology, hardware, software, and more. With years of experience in tech news and ...

On its face, the Insta360 X4 Air doesn't appear to be much of a departure from Insta360's flagship X5 camera, or indeed its older X4 camera. However, there are major changes to be found under the hood ...

X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $5.41 per share a year ago. These figures ...

BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare hematology diseases, today reported financial results for the ...